Index by author
September 01, 1996; Volume 278,Issue 3
A
Aarbakke, J
- You have accessApoptosis and transmethylation metabolites in HL-60 cells.P C Endresen, T Loennechen, H Kildalsen and J AarbakkeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1318-1324;
Abel, P W
- You have accessAlpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats.C S Bockman, I Gonzalez-Cabrera and P W AbelJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1235-1243;
Abood, M E
- You have accessEvaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.V M Showalter, D R Compton, B R Martin and M E AboodJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 989-999;
Aceto, M D
- You have accessDependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.M D Aceto, S M Scates, J A Lowe and B R MartinJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1290-1295;
Aghajanian, G K
- You have accessLSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.G J Marek and G K AghajanianJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1373-1382;
Akil, H
- You have accessCharacterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.P J Emmerson, M J Clark, A Mansour, H Akil, J H Woods and F MedzihradskyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1121-1127;
Albuquerque, E X
- You have accessParaoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons.E S Rocha, K L Swanson, Y Aracava, J E Goolsby, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1175-1187;
- You have accessDiversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release.M Alkondon, E S Rocha, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1460-1471;
- You have accessAlpha-conotoxin-ImI: a competitive antagonist at alpha-bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons.E F Pereira, M Alkondon, J M McIntosh and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1472-1483;
Aliño, S F
- You have accessSpecific serological response by active immunization with GD3-bearing liposomes.O Massó, S F Aliño, M Lejarreta, F Blasco and J PiulatsJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1114-1120;
Alkondon, M
- You have accessDiversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release.M Alkondon, E S Rocha, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1460-1471;
- You have accessAlpha-conotoxin-ImI: a competitive antagonist at alpha-bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons.E F Pereira, M Alkondon, J M McIntosh and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1472-1483;
Aracava, Y
- You have accessParaoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons.E S Rocha, K L Swanson, Y Aracava, J E Goolsby, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1175-1187;
Araki, H
- You have accessEffects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.T Takahashi, K Takahashi, S Kishi-Tanikawa, K Tsuchida, H Araki and S HiguchiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1028-1033;
Archer, S
- You have accessEffects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.M B Gatch, S S Negus, N K Mello, S Archer and J M BidlackJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1282-1289;
Artigas, F
- You have accessIn vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.N Bel and F ArtigasJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1064-1072;
Avram, M J
- You have accessRecirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly.T C Krejcie, T K Henthorn, C U Niemann, C Klein, D K Gupta, W B Gentry, C A Shanks and M J AvramJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1050-1057;
B
Ballenger, C A
- You have accessPlatelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.M J Owens, C A Ballenger, D L Knight and C B NemeroffJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1040-1049;
Barbarito, E J
- You have accessTolerance to the anxiolytic effects of the triazolobenzodiazepines triazolam and alprazolam, as measured by the ingestion of a hypertonic sodium chloride solution in rats.E J Barbarito, C E Lau and J L FalkJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1201-1208;
Bazemore, S A
- You have accessSingle-dose hemodynamic toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after intravenous infusion to cynomolgus monkeys.T L Wallace, S A Bazemore, D J Kornbrust and P A CossumJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1306-1312;
- You have accessRepeat-dose toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after bolus intravenous administration to cynomolgus monkeys.T L Wallace, S A Bazemore, D J Kornbrust and P A CossumJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1313-1317;
Bean, J S
- You have accessInhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.T R Wiernicki, J S Bean, C Dell, A Williams, D Wood, R F Kauffman and J P SinghJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1452-1459;
Beijer, B
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
Bel, N
- You have accessIn vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.N Bel and F ArtigasJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1064-1072;
Bellward, G D
- You have accessPeripubertal androgen imprinting of rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase: pretranslational regulation and impact on microsomal drug activation.T K Chang and G D BellwardJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1383-1391;
Bend, J R
- You have accessMicrosomal cytochrome P450 peroxygenase metabolism of arachidonic acid in guinea pig liver.G P McCallum, A C Weedon, P Krug and J R BendJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1188-1194;
Benet, L Z
- You have accessIn vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.A I Haj-Yehia and L Z BenetJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1296-1305;
Beyer, M E
- You have accessSignificance of endothelinB receptors for myocardial contractility and myocardial energy metabolism.M E Beyer, G Slesak and H M HoffmeisterJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1228-1234;
Bidlack, J M
- You have accessEffects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.M B Gatch, S S Negus, N K Mello, S Archer and J M BidlackJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1282-1289;
Biscardi, R
- You have accessEffects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.M A Wilson, R Biscardi, M D Smith and S P WilsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1073-1082;
Blaschke, M
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
Blasco, F
- You have accessSpecific serological response by active immunization with GD3-bearing liposomes.O Massó, S F Aliño, M Lejarreta, F Blasco and J PiulatsJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1114-1120;
Bless, E P
- You have accessInvestigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.A E Kelley, E P Bless and C J SwansonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1499-1507;
Bockman, C S
- You have accessAlpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats.C S Bockman, I Gonzalez-Cabrera and P W AbelJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1235-1243;
Bost, J E
- You have accessEffects of cocaine on anterior pituitary and gonadal hormones.C M Heesch, B H Negus, J E Bost, J H Keffer, R W Snyder and E J EichhornJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1195-1200;
Broudy, E P
- You have accessEndopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model.J A Schriefer, E P Broudy and A H HassenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1034-1039;
Buben, J A
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Buckpitt, A
- You have accessCellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.J Lakritz, A Chang, A Weir, S Nishio, D Hyde, R Philpot, A Buckpitt and C PlopperJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1408-1418;
Bylund, D B
- You have accessBuffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes.J D Deupree, K A Hinton, D R Cerutis and D B BylundJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1215-1227;
C
Calderon, S
- You have accessHuman delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.E Malatynska, Y Wang, R J Knapp, S Waite, S Calderon, K Rice, V J Hruby, H I Yamamura and W R RoeskeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1083-1089;
Cameron, N E
- You have accessEffects of a nonpeptide endothelin-1 ETA antagonist on neurovascular function in diabetic rats: interaction with the renin-angiotensin system.N E Cameron and M A CotterJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1262-1268;
Canet, E
- You have accessIn vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.L Foissier, M Lonchampt, F Cogé and E CanetJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1484-1490;
Caraco, Y
- You have accessPharmacogenetic determination of the effects of codeine and prediction of drug interactions.Y Caraco, J Sheller and A J WoodJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1165-1174;
Cerutis, D R
- You have accessBuffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes.J D Deupree, K A Hinton, D R Cerutis and D B BylundJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1215-1227;
Cervera, L S
- You have accessExpression and modulation of 5-hydroxytryptamine1A receptors in P11 cells.J G Hensler, L S Cervera, H A Miller and J CorbittJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1138-1145;
Cervoni, P
- You have accessDifferences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.Y T Shen, P Cervoni, T Claus and S F VatnerJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1435-1443;
Chang, A
- You have accessCellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.J Lakritz, A Chang, A Weir, S Nishio, D Hyde, R Philpot, A Buckpitt and C PlopperJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1408-1418;
Chang, T K
- You have accessPeripubertal androgen imprinting of rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase: pretranslational regulation and impact on microsomal drug activation.T K Chang and G D BellwardJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1383-1391;
Cheng, J B
- You have accessThe in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.C R Turner, V L Cohan, J B Cheng, H J Showell, C J Pazoles and J W WatsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1349-1355;
- You have accessIn vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.V L Cohan, H J Showell, D A Fisher, C J Pazoles, J W Watson, C R Turner and J B ChengJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1356-1361;
Clark, M J
- You have accessCharacterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.P J Emmerson, M J Clark, A Mansour, H Akil, J H Woods and F MedzihradskyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1121-1127;
Claus, T
- You have accessDifferences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.Y T Shen, P Cervoni, T Claus and S F VatnerJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1435-1443;
Codd, E E
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Cogé, F
- You have accessIn vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.L Foissier, M Lonchampt, F Cogé and E CanetJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1484-1490;
Cohan, V L
- You have accessThe in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.C R Turner, V L Cohan, J B Cheng, H J Showell, C J Pazoles and J W WatsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1349-1355;
- You have accessIn vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.V L Cohan, H J Showell, D A Fisher, C J Pazoles, J W Watson, C R Turner and J B ChengJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1356-1361;
Compton, D R
- You have accessEvaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.V M Showalter, D R Compton, B R Martin and M E AboodJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 989-999;
Connelly, C D
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Corbitt, J
- You have accessExpression and modulation of 5-hydroxytryptamine1A receptors in P11 cells.J G Hensler, L S Cervera, H A Miller and J CorbittJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1138-1145;
Cossum, P A
- You have accessSingle-dose hemodynamic toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after intravenous infusion to cynomolgus monkeys.T L Wallace, S A Bazemore, D J Kornbrust and P A CossumJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1306-1312;
- You have accessRepeat-dose toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after bolus intravenous administration to cynomolgus monkeys.T L Wallace, S A Bazemore, D J Kornbrust and P A CossumJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1313-1317;
Cotter, M A
- You have accessEffects of a nonpeptide endothelin-1 ETA antagonist on neurovascular function in diabetic rats: interaction with the renin-angiotensin system.N E Cameron and M A CotterJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1262-1268;
Czernik, A J
- You have accessIncreased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine.S Iwata, G H Hewlett, S T Ferrell, A J Czernik, K F Meiri and M E GnegyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1428-1434;
D
Davis, C
- You have accessInterindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene.N R Kitteringham, C Davis, N Howard, M Pirmohamed and B K ParkJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1018-1027;
Dell, C
- You have accessInhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.T R Wiernicki, J S Bean, C Dell, A Williams, D Wood, R F Kauffman and J P SinghJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1452-1459;
Desjardins, J P
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
Deupree, J D
- You have accessBuffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes.J D Deupree, K A Hinton, D R Cerutis and D B BylundJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1215-1227;
Dionisotti, S
- You have accessLabeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.S Dionisotti, S Ferrara, C Molta, C Zocchi and E OnginiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1209-1214;
Dunkel, M
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
E
Eichhorn, E J
- You have accessEffects of cocaine on anterior pituitary and gonadal hormones.C M Heesch, B H Negus, J E Bost, J H Keffer, R W Snyder and E J EichhornJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1195-1200;
Emmerson, P J
- You have accessCharacterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.P J Emmerson, M J Clark, A Mansour, H Akil, J H Woods and F MedzihradskyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1121-1127;
Endresen, P C
- You have accessApoptosis and transmethylation metabolites in HL-60 cells.P C Endresen, T Loennechen, H Kildalsen and J AarbakkeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1318-1324;
F
Falk, J L
- You have accessTolerance to the anxiolytic effects of the triazolobenzodiazepines triazolam and alprazolam, as measured by the ingestion of a hypertonic sodium chloride solution in rats.E J Barbarito, C E Lau and J L FalkJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1201-1208;
Ferrara, S
- You have accessLabeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.S Dionisotti, S Ferrara, C Molta, C Zocchi and E OnginiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1209-1214;
Ferrell, S T
- You have accessIncreased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine.S Iwata, G H Hewlett, S T Ferrell, A J Czernik, K F Meiri and M E GnegyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1428-1434;
Ferrier, G R
- You have accessLosartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischemia and reperfusion.G P Thomas, G R Ferrier and S E HowlettJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1090-1097;
Fischman, M W
- You have accessEffects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans.R W Foltin and M W FischmanJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1153-1164;
Fisher, D A
- You have accessIn vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.V L Cohan, H J Showell, D A Fisher, C J Pazoles, J W Watson, C R Turner and J B ChengJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1356-1361;
Foissier, L
- You have accessIn vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.L Foissier, M Lonchampt, F Cogé and E CanetJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1484-1490;
Foltin, R W
- You have accessEffects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans.R W Foltin and M W FischmanJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1153-1164;
Friden, P M
- You have accessCharacterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.P M Friden, T S Olson, R Obar, L R Walus and S D PutneyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1491-1498;
G
Gamache, D A
- You have accessCharacterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.N A Sharif, S X Xu, S T Miller, D A Gamache and J M YanniJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1252-1261;
Gatch, M B
- You have accessEffects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.M B Gatch, S S Negus, N K Mello, S Archer and J M BidlackJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1282-1289;
Gentry, W B
- You have accessRecirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly.T C Krejcie, T K Henthorn, C U Niemann, C Klein, D K Gupta, W B Gentry, C A Shanks and M J AvramJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1050-1057;
Gerdes, W
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
Gnegy, M E
- You have accessIncreased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine.S Iwata, G H Hewlett, S T Ferrell, A J Czernik, K F Meiri and M E GnegyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1428-1434;
Gonzalez-Cabrera, I
- You have accessAlpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats.C S Bockman, I Gonzalez-Cabrera and P W AbelJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1235-1243;
Goolsby, J E
- You have accessParaoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons.E S Rocha, K L Swanson, Y Aracava, J E Goolsby, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1175-1187;
Gunther, R
- You have accessMethotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.C May, R I James, R Gunther and R S McIvorJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1444-1451;
Gupta, D K
- You have accessRecirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly.T C Krejcie, T K Henthorn, C U Niemann, C Klein, D K Gupta, W B Gentry, C A Shanks and M J AvramJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1050-1057;
H
Haj-Yehia, A I
- You have accessIn vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.A I Haj-Yehia and L Z BenetJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1296-1305;
Haslego, M L
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Hassen, A H
- You have accessEndopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model.J A Schriefer, E P Broudy and A H HassenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1034-1039;
Hayaishi, O
- You have accessProstaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.T Minami, E Okuda-Ashitaka, H Mori, S Ito and O HayaishiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1146-1152;
Heesch, C M
- You have accessEffects of cocaine on anterior pituitary and gonadal hormones.C M Heesch, B H Negus, J E Bost, J H Keffer, R W Snyder and E J EichhornJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1195-1200;
Hensler, J G
- You have accessExpression and modulation of 5-hydroxytryptamine1A receptors in P11 cells.J G Hensler, L S Cervera, H A Miller and J CorbittJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1138-1145;
Henthorn, T K
- You have accessRecirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly.T C Krejcie, T K Henthorn, C U Niemann, C Klein, D K Gupta, W B Gentry, C A Shanks and M J AvramJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1050-1057;
Hewlett, G H
- You have accessIncreased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine.S Iwata, G H Hewlett, S T Ferrell, A J Czernik, K F Meiri and M E GnegyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1428-1434;
Higuchi, S
- You have accessEffects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.T Takahashi, K Takahashi, S Kishi-Tanikawa, K Tsuchida, H Araki and S HiguchiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1028-1033;
Hinton, K A
- You have accessBuffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes.J D Deupree, K A Hinton, D R Cerutis and D B BylundJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1215-1227;
Hirasaki, A
- You have accessUse of nitric oxide-nucleophile adducts as biological sources of nitric oxide: effects on airway smooth muscle.A Hirasaki, K A Jones, W J Perkins and D O WarnerJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1269-1275;
Hoffmeister, H M
- You have accessSignificance of endothelinB receptors for myocardial contractility and myocardial energy metabolism.M E Beyer, G Slesak and H M HoffmeisterJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1228-1234;
Hosokawa, M
- You have accessONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro.M Tominaga, H Tsukada, M Hosokawa, H Nakamura, T Taniguchi, S Ueda, M Sakai and M OkumaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1058-1063;
Howard, N
- You have accessInterindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene.N R Kitteringham, C Davis, N Howard, M Pirmohamed and B K ParkJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1018-1027;
Howlett, S E
- You have accessLosartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischemia and reperfusion.G P Thomas, G R Ferrier and S E HowlettJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1090-1097;
Hruby, V J
- You have accessHuman delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.E Malatynska, Y Wang, R J Knapp, S Waite, S Calderon, K Rice, V J Hruby, H I Yamamura and W R RoeskeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1083-1089;
Hyde, D
- You have accessCellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.J Lakritz, A Chang, A Weir, S Nishio, D Hyde, R Philpot, A Buckpitt and C PlopperJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1408-1418;
I
Ito, S
- You have accessProstaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.T Minami, E Okuda-Ashitaka, H Mori, S Ito and O HayaishiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1146-1152;
Iversen, P L
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
Iwasa, S
- You have accessCellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.D Nakai, T Seita, T Terasaki, S Iwasa, Y Shoji, Y Mizushima and Y SugiyamaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1362-1372;
Iwata, S
- You have accessIncreased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine.S Iwata, G H Hewlett, S T Ferrell, A J Czernik, K F Meiri and M E GnegyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1428-1434;
J
James, R I
- You have accessMethotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.C May, R I James, R Gunther and R S McIvorJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1444-1451;
Jones, K A
- You have accessUse of nitric oxide-nucleophile adducts as biological sources of nitric oxide: effects on airway smooth muscle.A Hirasaki, K A Jones, W J Perkins and D O WarnerJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1269-1275;
K
Kamada, H
- You have accessMolecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.Y Tsutsumi, T Kihira, S Tsunoda, H Kamada, S Nakagawa, Y Kaneda, T Kanamori and T MayumiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1006-1011;
Kanamori, T
- You have accessMolecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.Y Tsutsumi, T Kihira, S Tsunoda, H Kamada, S Nakagawa, Y Kaneda, T Kanamori and T MayumiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1006-1011;
Kaneda, Y
- You have accessMolecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.Y Tsutsumi, T Kihira, S Tsunoda, H Kamada, S Nakagawa, Y Kaneda, T Kanamori and T MayumiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1006-1011;
Karim, F
- You have accessSpinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels.Z Y Wei, F Karim and S C RoerigJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1392-1407;
Kauffman, R F
- You have accessInhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.T R Wiernicki, J S Bean, C Dell, A Williams, D Wood, R F Kauffman and J P SinghJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1452-1459;
Keffer, J H
- You have accessEffects of cocaine on anterior pituitary and gonadal hormones.C M Heesch, B H Negus, J E Bost, J H Keffer, R W Snyder and E J EichhornJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1195-1200;
Kelley, A E
- You have accessInvestigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.A E Kelley, E P Bless and C J SwansonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1499-1507;
Kihira, T
- You have accessMolecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.Y Tsutsumi, T Kihira, S Tsunoda, H Kamada, S Nakagawa, Y Kaneda, T Kanamori and T MayumiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1006-1011;
Kildalsen, H
- You have accessApoptosis and transmethylation metabolites in HL-60 cells.P C Endresen, T Loennechen, H Kildalsen and J AarbakkeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1318-1324;
Kishi-Tanikawa, S
- You have accessEffects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.T Takahashi, K Takahashi, S Kishi-Tanikawa, K Tsuchida, H Araki and S HiguchiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1028-1033;
Kitteringham, N R
- You have accessInterindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene.N R Kitteringham, C Davis, N Howard, M Pirmohamed and B K ParkJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1018-1027;
Klein, C
- You have accessRecirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly.T C Krejcie, T K Henthorn, C U Niemann, C Klein, D K Gupta, W B Gentry, C A Shanks and M J AvramJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1050-1057;
Knapp, R J
- You have accessHuman delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.E Malatynska, Y Wang, R J Knapp, S Waite, S Calderon, K Rice, V J Hruby, H I Yamamura and W R RoeskeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1083-1089;
Knight, D L
- You have accessPlatelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.M J Owens, C A Ballenger, D L Knight and C B NemeroffJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1040-1049;
Kornbrust, D J
- You have accessSingle-dose hemodynamic toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after intravenous infusion to cynomolgus monkeys.T L Wallace, S A Bazemore, D J Kornbrust and P A CossumJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1306-1312;
- You have accessRepeat-dose toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after bolus intravenous administration to cynomolgus monkeys.T L Wallace, S A Bazemore, D J Kornbrust and P A CossumJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1313-1317;
Krejcie, T C
- You have accessRecirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly.T C Krejcie, T K Henthorn, C U Niemann, C Klein, D K Gupta, W B Gentry, C A Shanks and M J AvramJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1050-1057;
Krone, M
- You have accessIs inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors?M Weiss, E M Schneider, J Tarnow, S Mettler, M Krone, A Teschemacher and H LemoineJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1105-1113;
Krug, P
- You have accessMicrosomal cytochrome P450 peroxygenase metabolism of arachidonic acid in guinea pig liver.G P McCallum, A C Weedon, P Krug and J R BendJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1188-1194;
L
Lakritz, J
- You have accessCellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.J Lakritz, A Chang, A Weir, S Nishio, D Hyde, R Philpot, A Buckpitt and C PlopperJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1408-1418;
Lau, C E
- You have accessTolerance to the anxiolytic effects of the triazolobenzodiazepines triazolam and alprazolam, as measured by the ingestion of a hypertonic sodium chloride solution in rats.E J Barbarito, C E Lau and J L FalkJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1201-1208;
Lejarreta, M
- You have accessSpecific serological response by active immunization with GD3-bearing liposomes.O Massó, S F Aliño, M Lejarreta, F Blasco and J PiulatsJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1114-1120;
Lemasters, J J
- You have accessThe mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury.L C Trost and J J LemastersJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1000-1005;
Lemoine, H
- You have accessIs inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors?M Weiss, E M Schneider, J Tarnow, S Mettler, M Krone, A Teschemacher and H LemoineJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1105-1113;
Lewis, T A
- You have accessGallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.T A Lewis, A E Munson and K L McCoyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1244-1251;
Loennechen, T
- You have accessApoptosis and transmethylation metabolites in HL-60 cells.P C Endresen, T Loennechen, H Kildalsen and J AarbakkeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1318-1324;
Lonchampt, M
- You have accessIn vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.L Foissier, M Lonchampt, F Cogé and E CanetJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1484-1490;
Lowe, J A
- You have accessDependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.M D Aceto, S M Scates, J A Lowe and B R MartinJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1290-1295;
Ludwig, J
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
M
Maelicke, A
- You have accessParaoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons.E S Rocha, K L Swanson, Y Aracava, J E Goolsby, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1175-1187;
- You have accessDiversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release.M Alkondon, E S Rocha, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1460-1471;
Malatynska, E
- You have accessHuman delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.E Malatynska, Y Wang, R J Knapp, S Waite, S Calderon, K Rice, V J Hruby, H I Yamamura and W R RoeskeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1083-1089;
Mansour, A
- You have accessCharacterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.P J Emmerson, M J Clark, A Mansour, H Akil, J H Woods and F MedzihradskyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1121-1127;
Marek, G J
- You have accessLSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.G J Marek and G K AghajanianJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1373-1382;
Martin, B R
- You have accessDependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.M D Aceto, S M Scates, J A Lowe and B R MartinJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1290-1295;
- You have accessEvaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.V M Showalter, D R Compton, B R Martin and M E AboodJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 989-999;
Martinez, R P
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Maryanoff, C A
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Massó, O
- You have accessSpecific serological response by active immunization with GD3-bearing liposomes.O Massó, S F Aliño, M Lejarreta, F Blasco and J PiulatsJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1114-1120;
May, C
- You have accessMethotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.C May, R I James, R Gunther and R S McIvorJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1444-1451;
Mayumi, T
- You have accessMolecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.Y Tsutsumi, T Kihira, S Tsunoda, H Kamada, S Nakagawa, Y Kaneda, T Kanamori and T MayumiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1006-1011;
McCallum, G P
- You have accessMicrosomal cytochrome P450 peroxygenase metabolism of arachidonic acid in guinea pig liver.G P McCallum, A C Weedon, P Krug and J R BendJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1188-1194;
McCoy, K L
- You have accessGallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.T A Lewis, A E Munson and K L McCoyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1244-1251;
McIntosh, J M
- You have accessAlpha-conotoxin-ImI: a competitive antagonist at alpha-bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons.E F Pereira, M Alkondon, J M McIntosh and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1472-1483;
McIvor, R S
- You have accessMethotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.C May, R I James, R Gunther and R S McIvorJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1444-1451;
Mckown, L A
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Medzihradsky, F
- You have accessCharacterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.P J Emmerson, M J Clark, A Mansour, H Akil, J H Woods and F MedzihradskyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1121-1127;
Meiri, K F
- You have accessIncreased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine.S Iwata, G H Hewlett, S T Ferrell, A J Czernik, K F Meiri and M E GnegyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1428-1434;
Mello, N K
- You have accessEffects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.M B Gatch, S S Negus, N K Mello, S Archer and J M BidlackJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1282-1289;
Mettler, S
- You have accessIs inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors?M Weiss, E M Schneider, J Tarnow, S Mettler, M Krone, A Teschemacher and H LemoineJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1105-1113;
Miller, H A
- You have accessExpression and modulation of 5-hydroxytryptamine1A receptors in P11 cells.J G Hensler, L S Cervera, H A Miller and J CorbittJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1138-1145;
Miller, S T
- You have accessCharacterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.N A Sharif, S X Xu, S T Miller, D A Gamache and J M YanniJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1252-1261;
Minami, T
- You have accessProstaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.T Minami, E Okuda-Ashitaka, H Mori, S Ito and O HayaishiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1146-1152;
Mizushima, Y
- You have accessCellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.D Nakai, T Seita, T Terasaki, S Iwasa, Y Shoji, Y Mizushima and Y SugiyamaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1362-1372;
Molta, C
- You have accessLabeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.S Dionisotti, S Ferrara, C Molta, C Zocchi and E OnginiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1209-1214;
Mori, H
- You have accessProstaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.T Minami, E Okuda-Ashitaka, H Mori, S Ito and O HayaishiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1146-1152;
Munson, A E
- You have accessGallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.T A Lewis, A E Munson and K L McCoyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1244-1251;
N
Nakagawa, S
- You have accessMolecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.Y Tsutsumi, T Kihira, S Tsunoda, H Kamada, S Nakagawa, Y Kaneda, T Kanamori and T MayumiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1006-1011;
Nakai, D
- You have accessCellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.D Nakai, T Seita, T Terasaki, S Iwasa, Y Shoji, Y Mizushima and Y SugiyamaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1362-1372;
Nakamura, H
- You have accessONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro.M Tominaga, H Tsukada, M Hosokawa, H Nakamura, T Taniguchi, S Ueda, M Sakai and M OkumaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1058-1063;
Negus, B H
- You have accessEffects of cocaine on anterior pituitary and gonadal hormones.C M Heesch, B H Negus, J E Bost, J H Keffer, R W Snyder and E J EichhornJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1195-1200;
Negus, S S
- You have accessEffects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.M B Gatch, S S Negus, N K Mello, S Archer and J M BidlackJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1282-1289;
Nemeroff, C B
- You have accessPlatelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.M J Owens, C A Ballenger, D L Knight and C B NemeroffJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1040-1049;
Niemann, C U
- You have accessRecirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly.T C Krejcie, T K Henthorn, C U Niemann, C Klein, D K Gupta, W B Gentry, C A Shanks and M J AvramJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1050-1057;
Nishio, S
- You have accessCellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.J Lakritz, A Chang, A Weir, S Nishio, D Hyde, R Philpot, A Buckpitt and C PlopperJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1408-1418;
O
Obar, R
- You have accessCharacterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.P M Friden, T S Olson, R Obar, L R Walus and S D PutneyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1491-1498;
Okuda-Ashitaka, E
- You have accessProstaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.T Minami, E Okuda-Ashitaka, H Mori, S Ito and O HayaishiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1146-1152;
Okuma, M
- You have accessONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro.M Tominaga, H Tsukada, M Hosokawa, H Nakamura, T Taniguchi, S Ueda, M Sakai and M OkumaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1058-1063;
Olson, T S
- You have accessCharacterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.P M Friden, T S Olson, R Obar, L R Walus and S D PutneyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1491-1498;
Ongini, E
- You have accessLabeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.S Dionisotti, S Ferrara, C Molta, C Zocchi and E OnginiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1209-1214;
Owens, M J
- You have accessPlatelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.M J Owens, C A Ballenger, D L Knight and C B NemeroffJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1040-1049;
P
Park, B K
- You have accessInterindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene.N R Kitteringham, C Davis, N Howard, M Pirmohamed and B K ParkJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1018-1027;
Pazoles, C J
- You have accessThe in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.C R Turner, V L Cohan, J B Cheng, H J Showell, C J Pazoles and J W WatsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1349-1355;
- You have accessIn vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.V L Cohan, H J Showell, D A Fisher, C J Pazoles, J W Watson, C R Turner and J B ChengJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1356-1361;
Pereira, E F
- You have accessAlpha-conotoxin-ImI: a competitive antagonist at alpha-bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons.E F Pereira, M Alkondon, J M McIntosh and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1472-1483;
Perkins, W J
- You have accessUse of nitric oxide-nucleophile adducts as biological sources of nitric oxide: effects on airway smooth muscle.A Hirasaki, K A Jones, W J Perkins and D O WarnerJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1269-1275;
Philpot, R
- You have accessCellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.J Lakritz, A Chang, A Weir, S Nishio, D Hyde, R Philpot, A Buckpitt and C PlopperJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1408-1418;
Pirmohamed, M
- You have accessInterindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene.N R Kitteringham, C Davis, N Howard, M Pirmohamed and B K ParkJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1018-1027;
Piulats, J
- You have accessSpecific serological response by active immunization with GD3-bearing liposomes.O Massó, S F Aliño, M Lejarreta, F Blasco and J PiulatsJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1114-1120;
Plopper, C
- You have accessCellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.J Lakritz, A Chang, A Weir, S Nishio, D Hyde, R Philpot, A Buckpitt and C PlopperJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1408-1418;
Pruett, S B
- You have accessSuppression of splenic natural killer cell activity in a mouse model for binge drinking. I. Direct effects of ethanol and its major metabolites are not primarily responsible for decreased natural killer cell activity.W J Wu and S B PruettJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1325-1330;
- You have accessSuppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system.W J Wu and S B PruettJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1331-1339;
Putney, S D
- You have accessCharacterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.P M Friden, T S Olson, R Obar, L R Walus and S D PutneyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1491-1498;
R
Raffa, R B
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Reith, M E
- You have accessModeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?C Xu and M E ReithJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1340-1348;
Reither, V
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
Rice, K
- You have accessHuman delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.E Malatynska, Y Wang, R J Knapp, S Waite, S Calderon, K Rice, V J Hruby, H I Yamamura and W R RoeskeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1083-1089;
Rocha, E S
- You have accessParaoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons.E S Rocha, K L Swanson, Y Aracava, J E Goolsby, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1175-1187;
- You have accessDiversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release.M Alkondon, E S Rocha, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1460-1471;
Roerig, S C
- You have accessSpinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels.Z Y Wei, F Karim and S C RoerigJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1392-1407;
Roeske, W R
- You have accessHuman delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.E Malatynska, Y Wang, R J Knapp, S Waite, S Calderon, K Rice, V J Hruby, H I Yamamura and W R RoeskeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1083-1089;
Rupp, T
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
S
Sakai, M
- You have accessONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro.M Tominaga, H Tsukada, M Hosokawa, H Nakamura, T Taniguchi, S Ueda, M Sakai and M OkumaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1058-1063;
Scates, S M
- You have accessDependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.M D Aceto, S M Scates, J A Lowe and B R MartinJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1290-1295;
Scheidegger, K J
- You have accessEffects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.K J Scheidegger, J M Wood, H van Essen and H A Struijker-BoudierJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1276-1281;
Schneider, E M
- You have accessIs inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors?M Weiss, E M Schneider, J Tarnow, S Mettler, M Krone, A Teschemacher and H LemoineJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1105-1113;
Schnellmann, R G
- You have accessExtracellular acidosis and chloride channel inhibitors act in the late phase of cellular injury to prevent death.S L Waters and R G SchnellmannJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1012-1017;
Schriefer, J A
- You have accessEndopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model.J A Schriefer, E P Broudy and A H HassenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1034-1039;
Schupsky, J J
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Seita, T
- You have accessCellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.D Nakai, T Seita, T Terasaki, S Iwasa, Y Shoji, Y Mizushima and Y SugiyamaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1362-1372;
Shanks, C A
- You have accessRecirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly.T C Krejcie, T K Henthorn, C U Niemann, C Klein, D K Gupta, W B Gentry, C A Shanks and M J AvramJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1050-1057;
Sharif, N A
- You have accessCharacterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.N A Sharif, S X Xu, S T Miller, D A Gamache and J M YanniJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1252-1261;
Sheller, J
- You have accessPharmacogenetic determination of the effects of codeine and prediction of drug interactions.Y Caraco, J Sheller and A J WoodJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1165-1174;
Shen, Y T
- You have accessDifferences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.Y T Shen, P Cervoni, T Claus and S F VatnerJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1435-1443;
Shoji, Y
- You have accessCellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.D Nakai, T Seita, T Terasaki, S Iwasa, Y Shoji, Y Mizushima and Y SugiyamaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1362-1372;
Showalter, V M
- You have accessEvaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.V M Showalter, D R Compton, B R Martin and M E AboodJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 989-999;
Showell, H J
- You have accessThe in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.C R Turner, V L Cohan, J B Cheng, H J Showell, C J Pazoles and J W WatsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1349-1355;
- You have accessIn vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.V L Cohan, H J Showell, D A Fisher, C J Pazoles, J W Watson, C R Turner and J B ChengJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1356-1361;
Singh, J P
- You have accessInhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.T R Wiernicki, J S Bean, C Dell, A Williams, D Wood, R F Kauffman and J P SinghJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1452-1459;
Slesak, G
- You have accessSignificance of endothelinB receptors for myocardial contractility and myocardial energy metabolism.M E Beyer, G Slesak and H M HoffmeisterJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1228-1234;
Smith, M D
- You have accessEffects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.M A Wilson, R Biscardi, M D Smith and S P WilsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1073-1082;
Snyder, R W
- You have accessEffects of cocaine on anterior pituitary and gonadal hormones.C M Heesch, B H Negus, J E Bost, J H Keffer, R W Snyder and E J EichhornJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1195-1200;
Spealman, R D
- You have accessDopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys.R D SpealmanJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1128-1137;
Sproat, B S
- You have accessPharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.J P Desjardins, B S Sproat, B Beijer, M Blaschke, M Dunkel, W Gerdes, J Ludwig, V Reither, T Rupp and P L IversenJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1419-1427;
Struijker-Boudier, H A
- You have accessEffects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.K J Scheidegger, J M Wood, H van Essen and H A Struijker-BoudierJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1276-1281;
Sugiyama, Y
- You have accessCellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.D Nakai, T Seita, T Terasaki, S Iwasa, Y Shoji, Y Mizushima and Y SugiyamaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1362-1372;
Swanson, C J
- You have accessInvestigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.A E Kelley, E P Bless and C J SwansonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1499-1507;
Swanson, K L
- You have accessParaoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons.E S Rocha, K L Swanson, Y Aracava, J E Goolsby, A Maelicke and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1175-1187;
T
Takacs, A N
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
Takahashi, K
- You have accessEffects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.T Takahashi, K Takahashi, S Kishi-Tanikawa, K Tsuchida, H Araki and S HiguchiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1028-1033;
Takahashi, T
- You have accessEffects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.T Takahashi, K Takahashi, S Kishi-Tanikawa, K Tsuchida, H Araki and S HiguchiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1028-1033;
Taniguchi, T
- You have accessONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro.M Tominaga, H Tsukada, M Hosokawa, H Nakamura, T Taniguchi, S Ueda, M Sakai and M OkumaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1058-1063;
Tarnow, J
- You have accessIs inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors?M Weiss, E M Schneider, J Tarnow, S Mettler, M Krone, A Teschemacher and H LemoineJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1105-1113;
Terasaki, T
- You have accessCellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.D Nakai, T Seita, T Terasaki, S Iwasa, Y Shoji, Y Mizushima and Y SugiyamaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1362-1372;
Teschemacher, A
- You have accessIs inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors?M Weiss, E M Schneider, J Tarnow, S Mettler, M Krone, A Teschemacher and H LemoineJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1105-1113;
Thomas, G P
- You have accessLosartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischemia and reperfusion.G P Thomas, G R Ferrier and S E HowlettJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1090-1097;
Tominaga, M
- You have accessONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro.M Tominaga, H Tsukada, M Hosokawa, H Nakamura, T Taniguchi, S Ueda, M Sakai and M OkumaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1058-1063;
Trost, L C
- You have accessThe mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury.L C Trost and J J LemastersJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1000-1005;
Tsuchida, K
- You have accessEffects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.T Takahashi, K Takahashi, S Kishi-Tanikawa, K Tsuchida, H Araki and S HiguchiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1028-1033;
Tsukada, H
- You have accessONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro.M Tominaga, H Tsukada, M Hosokawa, H Nakamura, T Taniguchi, S Ueda, M Sakai and M OkumaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1058-1063;
Tsunoda, S
- You have accessMolecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.Y Tsutsumi, T Kihira, S Tsunoda, H Kamada, S Nakagawa, Y Kaneda, T Kanamori and T MayumiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1006-1011;
Tsutsumi, Y
- You have accessMolecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.Y Tsutsumi, T Kihira, S Tsunoda, H Kamada, S Nakagawa, Y Kaneda, T Kanamori and T MayumiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1006-1011;
Turner, C R
- You have accessThe in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.C R Turner, V L Cohan, J B Cheng, H J Showell, C J Pazoles and J W WatsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1349-1355;
- You have accessIn vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.V L Cohan, H J Showell, D A Fisher, C J Pazoles, J W Watson, C R Turner and J B ChengJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1356-1361;
U
Ueda, S
- You have accessONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro.M Tominaga, H Tsukada, M Hosokawa, H Nakamura, T Taniguchi, S Ueda, M Sakai and M OkumaJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1058-1063;
V
van Essen, H
- You have accessEffects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.K J Scheidegger, J M Wood, H van Essen and H A Struijker-BoudierJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1276-1281;
Vatner, S F
- You have accessDifferences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.Y T Shen, P Cervoni, T Claus and S F VatnerJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1435-1443;
Villani, F J
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
W
Waite, S
- You have accessHuman delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.E Malatynska, Y Wang, R J Knapp, S Waite, S Calderon, K Rice, V J Hruby, H I Yamamura and W R RoeskeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1083-1089;
Wallace, T L
- You have accessSingle-dose hemodynamic toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after intravenous infusion to cynomolgus monkeys.T L Wallace, S A Bazemore, D J Kornbrust and P A CossumJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1306-1312;
- You have accessRepeat-dose toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after bolus intravenous administration to cynomolgus monkeys.T L Wallace, S A Bazemore, D J Kornbrust and P A CossumJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1313-1317;
Walus, L R
- You have accessCharacterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.P M Friden, T S Olson, R Obar, L R Walus and S D PutneyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1491-1498;
Wang, Y
- You have accessHuman delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.E Malatynska, Y Wang, R J Knapp, S Waite, S Calderon, K Rice, V J Hruby, H I Yamamura and W R RoeskeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1083-1089;
Warner, D O
- You have accessUse of nitric oxide-nucleophile adducts as biological sources of nitric oxide: effects on airway smooth muscle.A Hirasaki, K A Jones, W J Perkins and D O WarnerJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1269-1275;
Waters, S L
- You have accessExtracellular acidosis and chloride channel inhibitors act in the late phase of cellular injury to prevent death.S L Waters and R G SchnellmannJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1012-1017;
Watson, J W
- You have accessThe in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.C R Turner, V L Cohan, J B Cheng, H J Showell, C J Pazoles and J W WatsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1349-1355;
- You have accessIn vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.V L Cohan, H J Showell, D A Fisher, C J Pazoles, J W Watson, C R Turner and J B ChengJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1356-1361;
Weedon, A C
- You have accessMicrosomal cytochrome P450 peroxygenase metabolism of arachidonic acid in guinea pig liver.G P McCallum, A C Weedon, P Krug and J R BendJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1188-1194;
Wei, Z Y
- You have accessSpinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels.Z Y Wei, F Karim and S C RoerigJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1392-1407;
Weir, A
- You have accessCellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.J Lakritz, A Chang, A Weir, S Nishio, D Hyde, R Philpot, A Buckpitt and C PlopperJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1408-1418;
Weiss, M
- You have accessIs inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors?M Weiss, E M Schneider, J Tarnow, S Mettler, M Krone, A Teschemacher and H LemoineJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1105-1113;
Wiernicki, T R
- You have accessInhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.T R Wiernicki, J S Bean, C Dell, A Williams, D Wood, R F Kauffman and J P SinghJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1452-1459;
Williams, A
- You have accessInhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.T R Wiernicki, J S Bean, C Dell, A Williams, D Wood, R F Kauffman and J P SinghJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1452-1459;
Wilson, M A
- You have accessEffects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.M A Wilson, R Biscardi, M D Smith and S P WilsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1073-1082;
Wilson, S P
- You have accessEffects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.M A Wilson, R Biscardi, M D Smith and S P WilsonJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1073-1082;
Wood, A J
- You have accessPharmacogenetic determination of the effects of codeine and prediction of drug interactions.Y Caraco, J Sheller and A J WoodJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1165-1174;
Wood, D
- You have accessInhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.T R Wiernicki, J S Bean, C Dell, A Williams, D Wood, R F Kauffman and J P SinghJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1452-1459;
Wood, J M
- You have accessEffects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.K J Scheidegger, J M Wood, H van Essen and H A Struijker-BoudierJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1276-1281;
Woods, J H
- You have accessCharacterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.P J Emmerson, M J Clark, A Mansour, H Akil, J H Woods and F MedzihradskyJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1121-1127;
Wu, W J
- You have accessSuppression of splenic natural killer cell activity in a mouse model for binge drinking. I. Direct effects of ethanol and its major metabolites are not primarily responsible for decreased natural killer cell activity.W J Wu and S B PruettJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1325-1330;
- You have accessSuppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system.W J Wu and S B PruettJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1331-1339;
Wu, W N
- You have accessUnexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.R B Raffa, M L Haslego, C A Maryanoff, F J Villani, E E Codd, C D Connelly, R P Martinez, J J Schupsky, J A Buben, W N Wu, A N Takacs and L A MckownJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1098-1104;
X
Xu, C
- You have accessModeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?C Xu and M E ReithJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1340-1348;
Xu, S X
- You have accessCharacterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.N A Sharif, S X Xu, S T Miller, D A Gamache and J M YanniJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1252-1261;
Y
Yamamura, H I
- You have accessHuman delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.E Malatynska, Y Wang, R J Knapp, S Waite, S Calderon, K Rice, V J Hruby, H I Yamamura and W R RoeskeJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1083-1089;
Yanni, J M
- You have accessCharacterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.N A Sharif, S X Xu, S T Miller, D A Gamache and J M YanniJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1252-1261;
Z
Zocchi, C
- You have accessLabeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.S Dionisotti, S Ferrara, C Molta, C Zocchi and E OnginiJournal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1209-1214;
In this issue

Advertisement